Читать книгу "0,05. Доказательная медицина от магии до поисков бессмертия - Петр Талантов"

Macpherson H., Pipingas A., Pase M. P. Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials // The American journal of clinical nutrition. 2013. February. Vol. 97. № 2. P. 437–444.

The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers // The New England Journal of Medicine. 1994. April 14. Vol. 330. P. 1029–1035.

Bjelakovic G., Nikolova D., Simonetti R. G., Gluud C. Antioxidant supplements for preventing gastrointestinal cancers // Cochrane Database of Systematic Reviews. 2008. July. Vol. 16. № 3, CD004183.

Omenn G. S., M. D., Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R. et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease // The New England Journal of Medicine. 1996. May 2. Vol. 334. P. 1150–1155.

Miller E. R., Pastor-Barriuso R., Dalal D., Riemersma R. A., Appel L. J. et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality // Annals of Internal Medicine. 2005. Vol. 142. № 1. P. 37–46.

Dyerberg J. Coronary heart disease in Greenland Inuit: a paradox. Implications for western diet patterns // Arctic medical research. 1989. April. Vol. 48. № 2. P. 47–54.

Abdelhamid A. S., Brown T. J., Brainard J. S., Biswas P., Thorpe G. C. et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease // Cochrane Database of Systematic Reviews. 2018. № 7. Art. № CD003177.

Kwak S. M., Myung S. K., Lee Y. J., Seo H. G. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials // Archives of internal medicine. 2012. May 14. Vol. 172. № 9. P. 686–694.

Rizos E. C., Ntzani E. E., Bika E., Kostapanos M. S., Elisaf M. S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis // JAMA. 2012. September 12. Vol. 308. № 10. P. 1024–1033.

Aung T., Halsey J., Kromhout D. et al. Associations of Omega-3 fatty acid supplement use with cardiovascular disease risks. Meta-analysis of 10 trials involving 77 917 individuals // JAMA Cardiology. 2018. Vol. 3. № 3. P. 225–233.

Bhatt D. L., Steg P. G., Miller M., Brinton E. A., Jacobson T. A. et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia // The New England Journal of Medicine. 2019. January 3. Vol. 380. P. 11–22.

Manson J. E., Cook N. R., I – Min Lee, Christen W., Bassuk S. S. et al. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer // The New England Journal of Medicine. 2019. January 3. Vol. 380. P. 23–32.

Carroll A. E. Given Their Potential for Harm, It’s Time to Focus on the Safety of Supplements // JAMA. 2018. Vol. 320. № 13. P. 1306–1307.

Newmaster S. G., Grguric M., Shanmughanandhan D., Ramalingam S., Ragupathy S. DNA barcoding detects contamination and substitution in North American herbal products // BMC medicine. 2013. Vol. 11. № 1. P. 222.

Harmon K. Herbal supplement sellers dispense dangerous advice, false claims // Scientific American. 2010. May 28.

Geller A. I., Shehab N., Weidle N. J., Lovegrove M. C., Wolpert B. J. et al. Emergency department visits for adverse events related to dietary supplements // The New England Journal of Medicine. 2015. October 15. Vol. 373. P. 1531–1540.

Gregory P. Availability of DMAA supplements despite US food and drug administration action // JAMA Internal Medicine. 2013. Vol. 173. № 2. P. 164–165.

Zhang Y., Woods R. M., Breitbach Z. S., Armstrong D. W. 1,3-Dimethylamylamine (DMAA) in supplements and geranium products: natural or synthetic? // Drug Testing and Analysis. 2012. Vol. 4. P. 986–990.

Lindeboom G. A. The story of a blood transfusion to a pope // Journal of the History of Medicine and Allied Sciences. 1954. October 1. Vol. 9. № 4. P. 455–459.

Kaiser J. Blood from young people does little to reverse Alzheimer’s in first test // Science. 2017. November 1.

Cooper D. K. C. A brief history of cross-species organ transplantation // Proceedings (Baylor University. Medical Center). 2012. January. Vol. 25. № 1. P. 49–57.

Bajic P., Selman S. H., Rees M. A. Voronoff to virion: 1920s testis transplantation and AIDS // Xenotransplantation. 2012. November-December. Vol. 19. № 6. P. 337–341.

Setchell B. P. The testis and tissue transplantation: historical aspects // Journal of reproductive immunology. 1990. August. Vol. 18. № 1. P. 1–8.

Wang H., Zhao Y., Ezcurra M., Benedetto A., Gilliat A. F., Hellberg J., Ren Z. et al. A parthenogenetic quasi-program causes teratoma-like tumors during aging in wild-type C. elegans // npj Aging and Mechanisms of Disease. 2018. Vol. 4. Art. № 6.

Cheetham T. C., An J., Jacobsen S. J. et al. Association of testosterone replacement with cardiovascular outcomes among men with androgen deficiency // JAMA Internal Medicine. 2017. Vol. 177. № 4. P. 491–499.

Basaria S., Coviello A. D. Travison T. G., Storer T. W., Farwell W. R. et al. Adverse events associated with testosterone administration // The New England Journal of Medicine. 2010. July 8. Vol. 363. № 2. P. 109–122.

Bhasin S., Cunningham G. R., Hayes F. J., Matsumoto A. M., Snyder P. J. et al. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline // The Journal of Clinical Endocrinology & Metabolism. 2006. June 1. Vol. 91. № 6. P. 1995–2010.

Rudman D., Feller A. G., Nograj H. S., et al. Effects of human growth hormone in men over 60 years old // The New England Journal of Medicine. 1990. Vol. 323. № 1. P. 1–6.

Swerdlow A. J., Cooke R., Beckers D., Borgström B., Butler G. et al. Cancer risks in patients treated with growth hormone in childhood: the SAGhE European cohort study // The Journal of clinical endocrinology and metabolism. 2017. May 1. Vol. 102. № 5. P. 1661–1672.

Robida-Stubbs S., Glover-Cutter K., Lamming D. W., Mizunuma M. et al. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO // Cell metabolism. 2012. May 2. Vol. 15. № 5. P. 713–724.

Bhullar K. S., Hubbard B. P. Lifespan and healthspan extension by resveratrol // Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease. 2015. June. Vol. 1852. № 6. P. 1209–1218.